SCHEMBL14214971

SCHEMBL14214971

O=NCC(CN=O)N=O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15039695 0.81
SCHEMBL18726565 0.81
SCHEMBL17366329 0.81
SCHEMBL17813691 0.78
SCHEMBL17888106 0.78
SCHEMBL9063930 0.76
SCHEMBL24505633 0.73 CA2 (0.34)
SCHEMBL17366325 0.73 CA2 (0.34)
SCHEMBL17813119 0.73
SCHEMBL17281269 0.71

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3204040-B1 TREATMENT OF CANCER USING TLR9 AGONISTS AND CHECKPOINT INHIBITORS IDERA PHARMACEUTICALS INC (US) 2021-12-08 EP disclosed
EP-3015448-B1 METHOD FOR PRODUCING ACRYLIC ACID FROM GLYCEROL LG CHEMICAL LTD (KR) 2017-10-25 EP disclosed
EP-2675526-B1 NOVEL SULFONAMINOQUINOLINE HEPCIDIN ANTAGONISTS VIFOR (INTERNATIONAL) AG (CH) 2017-02-01 EP disclosed
EP-3015446-A1 METHOD FOR PRODUCING ALLYL ALCOHOL AND ALLYL ALCOHOL PRODUCED THEREBY LG Chem, Ltd. (KR) 2016-05-04 EP disclosed
US-7371780-B2 Use of calphostin C to treat drug-resistant tumor cells PARISSENTI, AMADEO, DR. (CA) 2008-05-13 US disclosed